Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access. But having a product ...

The price of weight-loss drugs has been dropping in 2026. At the same time, employers have been cutting back on their coverage of the drugs.

The recent federal reforms to pharmacy benefit managers are a meaningful step in the right direction, but the work is not ...

When 22-year-old Cole Schmidtknecht walked up to the pharmacy counter, he learned his Advair Diskus inhaler had jumped from under $70 to over $500. He walked away without the medicine. Within a week, ...

By Amina Niasse NEW YORK, June 2 (Reuters) - Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo ...

Cigna drop GLP coverage for employees on July 1, excluding Type 2 diabetes, amid rising cost pressures on employer health plans.

Eli Lilly (LLY) just did something worth paying attention to. With CVS Caremark announcing coverage of both Zepbound and ...

Yeztugo, a twice-yearly shot, could be the catalyst for stopping a recent spike in new HIV diagnoses. It's now available in ...

The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will restore coverage to obesity products from Eli Lilly, ...

CARDAMYST™ (etripamil) nasal spray launch for PSVT is gaining traction; breadth of unique prescribers supports potential future adoptionExpress ...

KBIA’s Rebecca Smith brings us the story of how some local, independent pharmacies are finding ways to diversify and expand ...

Milestone Pharma (MIST) stays a Hold after Q1 misses and a tough CARDAMYST launch; PSVT pricing, uptake, and payer risk loom.